Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

New horizons in multimodality molecular imaging and novel radiotracers

Sally Barrington, Philip Blower and Gary Cook
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.17-5-444
Clin Med October 2017
Sally Barrington
AKing’s College London and Guy’s & St Thomas’ PET Centre, London, UK
Roles: professor of PET imaging
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Blower
BKing’s College London, London, UK
Roles: professor of imaging chemistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Cook
CDepartment of Cancer Imaging and Guy’s & St Thomas’ PET Centre, King’s College London, London, UK
Roles: professor of PET imaging
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gary.cook@kcl.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    Takayasu’s arteritis. A – 18F-FDG PET/CT scan coronal images of a patient presenting with weight loss, fevers, drenching night sweats and proximal muscle weakness. PET (left), CT (middle) and fused PET/CT (right) images are shown indicating increased uptake in large vessels, subclavian and abdominal aorta (arrows) compatible with the final diagnosis of Takayasu’s giant cell arteritis. B – Repeat scan after 6 months with steroid therapy indicated reduction in uptake in the vessels. CT = computerised tomography; FDG = fluorodeoxyglucose; PET = positron emission tomography

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    18F-choline PET/MRI axial images of a patient with Gleason 4+3 prostate cancer. T2-weighted images (T2 SFOV) show a small area of low signal in the left posterior peripheral zone. There is restricted diffusion at this site on the ADC images, increased choline uptake on the fused T2/FDG PET image and increased blood flow compared to the normal prostate and normal muscle on the T1 DCE magnetic resonance images. ADC = apparent diffusion coefficient; DCE = dynamic contrast enhanced; FDG = fluorodeoxyglucose; MRI = magnetic resonance imaging; PET = positron emission tomography; SFOV = small field of view

Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
New horizons in multimodality molecular imaging and novel radiotracers
Sally Barrington, Philip Blower, Gary Cook
Clinical Medicine Oct 2017, 17 (5) 444-448; DOI: 10.7861/clinmedicine.17-5-444

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
New horizons in multimodality molecular imaging and novel radiotracers
Sally Barrington, Philip Blower, Gary Cook
Clinical Medicine Oct 2017, 17 (5) 444-448; DOI: 10.7861/clinmedicine.17-5-444
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Key points
    • Introduction
    • PET/CT
    • PET/MRI
    • Novel contrast agents
    • Conclusions
    • Conflicts of interest
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Winter is coming; time to ensure the right care, in the right place, for the right length of time
  • Google Scholar

More in this TOC Section

  • Molecular radiotheranostics for neuroendocrine tumours
  • CME Nuclear medicine (108462): self-assessment questionnaire
Show more CME Nuclear medicine

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians